Core Insights - Peninsula Medical has launched two significant products, the Peninsula Super Cannon and the Peninsula Counterclockwise, which are set to lead the medical aesthetics equipment industry towards standardization and represent a breakthrough for domestic technology in the global market [1][4][27]. Product Launch - The Peninsula Super Cannon is the first ultrasound skin treatment device to receive a Class III medical device registration from the Chinese National Medical Products Administration (NMPA) [1][27]. - The Peninsula Counterclockwise is the first domestic Class III radiofrequency skin treatment device to achieve dual certification from both the NMPA and the U.S. FDA [1][27]. Industry Impact - The introduction of these products is seen as a move towards standardization in the medical aesthetics industry, which is increasingly influenced by the "beauty economy" and advancements in photonic technology [5][12]. - The medical aesthetics equipment market in China has significant growth potential, with the penetration of photonic medical aesthetics technology driving the development of downstream services [16][30]. Research and Development - Peninsula Medical has invested heavily in R&D, allocating over 25% of its revenue annually, and has a dedicated R&D team of nearly 400 people, constituting 30% of its total workforce [21][27]. - The company has filed over 1,000 domestic and international patents, with more than 400 granted, establishing a strong technological moat [21]. Clinical Validation - The clinical trials for the Peninsula Super Cannon involved 204 subjects, showing an efficacy rate of over 82% in improving skin laxity, with a satisfaction rate exceeding 88% three months post-treatment [7][9]. - The clinical data for the Peninsula Counterclockwise indicated a scar improvement efficacy rate of over 96% and a satisfaction rate close to 98% three months after the procedure [9]. Market Position - Peninsula Medical has positioned itself among the top six global energy source medical aesthetics equipment companies, with its products sold in over 70 countries and regions, serving more than 10,000 well-known hospitals [27]. - The launch of these products marks a shift in the domestic medical aesthetics equipment landscape, moving from low-end market competition to achieving international certifications and recognition [27][30].
从跟跑到超越!半岛医疗三类证产品问世,国产医美设备开启全球竞争新篇
Di Yi Cai Jing·2025-12-10 10:50